Literature DB >> 2337274

Resistance to development of equine ehrlichial colitis in experimentally inoculated horses and ponies.

J E Palmer1, C E Benson, R H Whitlock.   

Abstract

Fourteen ponies and 3 horses were inoculated with Ehrlichia risticii 2 to 20 months after a similar initial inoculation. Although all 17 had clinical signs of equine ehrlichial colitis after the first inoculation, 16 of 17 remained clinically normal following the second inoculation. The remaining pony had a transient fever and developed signs of depression. Before the initial inoculation, none of the animals had a detectable antibody titer to E risticii. All animals developed titers after the initial infection; however, a significant change of titer did not develop after reinoculation in most animals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337274

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  5 in total

1.  Passive transfer of antibody to Ehrlichia risticii protects mice from ehrlichiosis.

Authors:  P S Kaylor; T B Crawford; T F McElwain; G H Palmer
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Association of deficiency in antibody response to vaccine and heterogeneity of Ehrlichia risticii strains with Potomac horse fever vaccine failure in horses.

Authors:  S K Dutta; R Vemulapalli; B Biswas
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 3.  Historical aspects of Potomac horse fever in Ontario (1924-2010).

Authors:  John D Baird; Luis G Arroyo
Journal:  Can Vet J       Date:  2013-06       Impact factor: 1.008

Review 4.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Identification of the protective 44-kilodalton recombinant antigen of Ehrlichia risticii.

Authors:  B Shankarappa; S K Dutta; B Mattingly-Napier
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.